AnPac Bio-Medical Science Co Profit Margin

The latest profit margin for ANPC is -841.28% as of December 2022. That compares with -660.08% in the prior-year period — down 27.5% year over year. That is below the Healthcare sector average of 21.34%. Investors often review this figure alongside AnPac Bio-Medical Science Co's historical trend and sector peers before judging valuation or financial health.

Over the past year, ANPC's profit margin moved from -660.08% to -841.28% — a 27.5% year-over-year decrease. If the trend continues in the same direction for several quarters, it can signal a meaningful shift in AnPac Bio-Medical Science Co's valuation or profitability profile.

Against Healthcare companies, ANPC currently prints -841.28% for profit margin, while the sector average sits near 21.34%. That is roughly 4043.2% below the sector mean. Large gaps often invite a closer look at AnPac Bio-Medical Science Co's growth, margins, and balance sheet.

Profit Margin shows how effectively AnPac Bio-Medical Science Co converts resources into returns. At -841.28%, ANPC may look efficient or underperforming depending on peer benchmarks and trend direction. That compares with -660.08% in the prior-year period — down 27.5% year over year. Pair the percentage with revenue growth and leverage for a fuller health check.

After noting ANPC's profit margin (-841.28%), review year-over-year change from -660.08%, peer averages, and a few neighboring metrics such as revenue, margins, or valuation multiples. That combination usually beats staring at a single figure. The navigation links on this page jump you to those related views.